| Product NDC: | 0527-1330 |
| Proprietary Name: | Baclofen |
| Non Proprietary Name: | baclofen |
| Active Ingredient(s): | 10 mg/1 & nbsp; baclofen |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0527-1330 |
| Labeler Name: | Lannett Company, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078220 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070701 |
| Package NDC: | 0527-1330-01 |
| Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (0527-1330-01) |
| NDC Code | 0527-1330-01 |
| Proprietary Name | Baclofen |
| Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (0527-1330-01) |
| Product NDC | 0527-1330 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | baclofen |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20070701 |
| Marketing Category Name | ANDA |
| Labeler Name | Lannett Company, Inc. |
| Substance Name | BACLOFEN |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | GABA A Agonists [MoA],GABA B Agonists [MoA],gamma-Aminobutyric Acid-ergic Agonist [EPC] |